Loading…

Use of niosomes for the treatment of intracellular pathogens infecting the lungs

The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing...

Full description

Saved in:
Bibliographic Details
Published in:Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2023-07, Vol.15 (4), p.e1891-n/a
Main Authors: Bach, Horacio, Lorenzo‐Leal, Ana C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193
cites cdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193
container_end_page n/a
container_issue 4
container_start_page e1891
container_title Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
container_volume 15
creator Bach, Horacio
Lorenzo‐Leal, Ana C.
description The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).
doi_str_mv 10.1002/wnan.1891
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2799170963</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2836192043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</originalsourceid><addsrcrecordid>eNp1kE1PwkAQhjdGI4ge_AOmiRc9FPar7e6REL8Sgh4kHjdLnUJJu4u72xD-vS2gBxNPM5l55s07L0LXBA8JxnS0NdoMiZDkBPWJZDLGmJPTY58QkvbQhfdrjFOe0uQc9ViGGU0x7aO3uYfIFpEprbc1-KiwLgoriIIDHWowoduWJjidQ1U1lXbRRoeVXYLx7byAPJRmuT-pGrP0l-is0JWHq2MdoPnjw_vkOZ6-Pr1MxtM4Z0KQOC-A61QKSTnmIAuda840EZAyojMiWq9YU7bgLKGMMpA5FjrBCyJ4LnT72ADdHXQ3zn414IOqS99Z1AZs4xXNpCQZlilr0ds_6No2zrTuFBUsJZJi3lH3Byp31nsHhdq4stZupwhWXcyqi1l1MbfszVGxWdTw-Uv-5NoCowOwLSvY_a-kPmbj2V7yG8rFhgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2836192043</pqid></control><display><type>article</type><title>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</title><source>Wiley</source><creator>Bach, Horacio ; Lorenzo‐Leal, Ana C.</creator><creatorcontrib>Bach, Horacio ; Lorenzo‐Leal, Ana C.</creatorcontrib><description>The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery &gt; Nanomedicine for Infectious Disease Nanotechnology Approaches to Biology &gt; Nanoscale Systems in Biology Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).</description><identifier>ISSN: 1939-5116</identifier><identifier>EISSN: 1939-0041</identifier><identifier>DOI: 10.1002/wnan.1891</identifier><identifier>PMID: 37032602</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Animals ; Biology ; Drug delivery ; Drug Delivery Systems ; Drugs ; Immune clearance ; Immune response ; Immune system ; Immunology ; Immunosuppressive agents ; Intracellular ; intracellular pathogens ; Leukocytes ; Liposomes ; Lung ; lung infection ; Lungs ; Macrophages ; Mammals ; mycobacteria ; nanocarriers ; Nanomedicine ; Nanotechnology ; niosomes ; Pathogens</subject><ispartof>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2023-07, Vol.15 (4), p.e1891-n/a</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</citedby><cites>FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</cites><orcidid>0000-0002-7740-9299</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37032602$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bach, Horacio</creatorcontrib><creatorcontrib>Lorenzo‐Leal, Ana C.</creatorcontrib><title>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</title><title>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</title><addtitle>Wiley Interdiscip Rev Nanomed Nanobiotechnol</addtitle><description>The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery &gt; Nanomedicine for Infectious Disease Nanotechnology Approaches to Biology &gt; Nanoscale Systems in Biology Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).</description><subject>Animals</subject><subject>Biology</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems</subject><subject>Drugs</subject><subject>Immune clearance</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunology</subject><subject>Immunosuppressive agents</subject><subject>Intracellular</subject><subject>intracellular pathogens</subject><subject>Leukocytes</subject><subject>Liposomes</subject><subject>Lung</subject><subject>lung infection</subject><subject>Lungs</subject><subject>Macrophages</subject><subject>Mammals</subject><subject>mycobacteria</subject><subject>nanocarriers</subject><subject>Nanomedicine</subject><subject>Nanotechnology</subject><subject>niosomes</subject><subject>Pathogens</subject><issn>1939-5116</issn><issn>1939-0041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kE1PwkAQhjdGI4ge_AOmiRc9FPar7e6REL8Sgh4kHjdLnUJJu4u72xD-vS2gBxNPM5l55s07L0LXBA8JxnS0NdoMiZDkBPWJZDLGmJPTY58QkvbQhfdrjFOe0uQc9ViGGU0x7aO3uYfIFpEprbc1-KiwLgoriIIDHWowoduWJjidQ1U1lXbRRoeVXYLx7byAPJRmuT-pGrP0l-is0JWHq2MdoPnjw_vkOZ6-Pr1MxtM4Z0KQOC-A61QKSTnmIAuda840EZAyojMiWq9YU7bgLKGMMpA5FjrBCyJ4LnT72ADdHXQ3zn414IOqS99Z1AZs4xXNpCQZlilr0ds_6No2zrTuFBUsJZJi3lH3Byp31nsHhdq4stZupwhWXcyqi1l1MbfszVGxWdTw-Uv-5NoCowOwLSvY_a-kPmbj2V7yG8rFhgQ</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Bach, Horacio</creator><creator>Lorenzo‐Leal, Ana C.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7740-9299</orcidid></search><sort><creationdate>202307</creationdate><title>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</title><author>Bach, Horacio ; Lorenzo‐Leal, Ana C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Biology</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems</topic><topic>Drugs</topic><topic>Immune clearance</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunology</topic><topic>Immunosuppressive agents</topic><topic>Intracellular</topic><topic>intracellular pathogens</topic><topic>Leukocytes</topic><topic>Liposomes</topic><topic>Lung</topic><topic>lung infection</topic><topic>Lungs</topic><topic>Macrophages</topic><topic>Mammals</topic><topic>mycobacteria</topic><topic>nanocarriers</topic><topic>Nanomedicine</topic><topic>Nanotechnology</topic><topic>niosomes</topic><topic>Pathogens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bach, Horacio</creatorcontrib><creatorcontrib>Lorenzo‐Leal, Ana C.</creatorcontrib><collection>Wiley-Blackwell Open Access Titles (Open Access)</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bach, Horacio</au><au>Lorenzo‐Leal, Ana C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</atitle><jtitle>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</jtitle><addtitle>Wiley Interdiscip Rev Nanomed Nanobiotechnol</addtitle><date>2023-07</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>e1891</spage><epage>n/a</epage><pages>e1891-n/a</pages><issn>1939-5116</issn><eissn>1939-0041</eissn><abstract>The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery &gt; Nanomedicine for Infectious Disease Nanotechnology Approaches to Biology &gt; Nanoscale Systems in Biology Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37032602</pmid><doi>10.1002/wnan.1891</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0002-7740-9299</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1939-5116
ispartof Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2023-07, Vol.15 (4), p.e1891-n/a
issn 1939-5116
1939-0041
language eng
recordid cdi_proquest_miscellaneous_2799170963
source Wiley
subjects Animals
Biology
Drug delivery
Drug Delivery Systems
Drugs
Immune clearance
Immune response
Immune system
Immunology
Immunosuppressive agents
Intracellular
intracellular pathogens
Leukocytes
Liposomes
Lung
lung infection
Lungs
Macrophages
Mammals
mycobacteria
nanocarriers
Nanomedicine
Nanotechnology
niosomes
Pathogens
title Use of niosomes for the treatment of intracellular pathogens infecting the lungs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A25%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20niosomes%20for%20the%20treatment%20of%20intracellular%20pathogens%20infecting%20the%20lungs&rft.jtitle=Wiley%20interdisciplinary%20reviews.%20Nanomedicine%20and%20nanobiotechnology&rft.au=Bach,%20Horacio&rft.date=2023-07&rft.volume=15&rft.issue=4&rft.spage=e1891&rft.epage=n/a&rft.pages=e1891-n/a&rft.issn=1939-5116&rft.eissn=1939-0041&rft_id=info:doi/10.1002/wnan.1891&rft_dat=%3Cproquest_cross%3E2836192043%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2836192043&rft_id=info:pmid/37032602&rfr_iscdi=true